Analysen von Michael Leuchten
| 07.02.20 | Roche buy | UBS AG | |
| 30.01.20 | Roche buy | UBS AG | |
| 10.01.20 | Roche buy | UBS AG | |
| 25.11.19 | Roche buy | UBS AG | |
| 19.11.19 | Bayer buy | UBS AG | |
| 14.11.19 | Roche buy | UBS AG | |
| 11.11.19 | Roche buy | UBS AG | |
| 07.11.19 | Roche buy | UBS AG | |
|
Werbung
|
|||
| 01.11.19 | Novo Nordisk buy | UBS AG | |
| 31.10.19 | Bayer buy | UBS AG | |
| 30.10.19 | Bayer buy | UBS AG | |
| 21.10.19 | Novo Nordisk buy | UBS AG | |
| 16.10.19 | Roche buy | UBS AG | |
| 17.09.19 | Roche buy | UBS AG | |
| 16.09.19 | Roche buy | UBS AG | |
| 05.09.19 | Bayer buy | UBS AG | |
| 02.09.19 | Novo Nordisk buy | UBS AG | |
| 09.08.19 | Novo Nordisk buy | UBS AG | |
| 31.07.19 | Bayer buy | UBS AG | |
| 31.07.19 | Novo Nordisk buy | UBS AG | |
| 30.07.19 | Bayer buy | UBS AG | |
| 26.07.19 | Roche buy | UBS AG | |
| 16.07.19 | Bayer buy | UBS AG | |
| 28.06.19 | Bayer buy | UBS AG | |
| 18.06.19 | Novo Nordisk buy | UBS AG | |
| 11.06.19 | Novo Nordisk buy | UBS AG | |
| 07.05.19 | Novo Nordisk buy | UBS AG | |
| 03.05.19 | Novo Nordisk buy | UBS AG | |
| 25.04.19 | Bayer buy | UBS AG | |
| 28.03.19 | Bayer buy | UBS AG | |
| 07.03.19 | Merck buy | UBS AG | |
| 27.02.19 | Bayer buy | UBS AG | |
| 22.02.19 | Bayer buy | UBS AG | |
| 12.02.19 | Bayer buy | UBS AG | |
| 07.02.19 | GSK buy | UBS AG | |
| 29.01.19 | Sartorius vz. buy | UBS AG | |
| 02.01.19 | GSK buy | UBS AG | |
| 13.12.18 | Sartorius vz. buy | UBS AG | |
| 06.12.18 | Bayer buy | UBS AG | |
| 04.12.18 | GSK buy | UBS AG | |
| 30.11.18 | Novo Nordisk buy | UBS AG | |
| 26.11.18 | Novo Nordisk buy | UBS AG | |
| 13.11.18 | Bayer buy | UBS AG | |
| 05.11.18 | Novo Nordisk buy | UBS AG | |
| 01.11.18 | Novo Nordisk buy | UBS AG | |
| 01.11.18 | GSK buy | UBS AG | |
| 23.10.18 | Bayer buy | UBS AG | |
| 17.10.18 | Merck buy | UBS AG | |
| 11.10.18 | Bayer buy | UBS AG | |
| 10.10.18 | Novo Nordisk buy | UBS AG | |